History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
Main Author: | |
---|---|
Publication Date: | 2024 |
Format: | Article |
Language: | por |
Source: | BEPA. Boletim epidemiológico paulista (Online) |
Download full: | https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435 |
Summary: | In the year in which we celebrate 30 years since the discovery of the etiological agent of Kaposi's sarcoma (KS), at the time named Kaposi's sarcoma-associated herpesvirus (KSHV), later Human Herpesvirus 8 (HHV-8), the author reports on the role of the Instituto Adolfo Lutz in searching this agent using molecular biology techniques, first in biopsy material stored in paraffin and then in blood, saliva and urine, and in the characterization of subtypes and viral variants of HHV-8 that circulated in patients with KS associated with AIDS (KS-AIDS) in São Paulo, and in indigenous populations from the Brazilian Amazon. Furthermore, in-house serological techniques (indirect immunofluorescence and Western blotting) were standardized using cell lines containing HHV-8 in the latent and lytic phases of viral infection as antigens, and serum or blood collected on filter membrane to search for specific antibodies. The best cost/benefit serological and molecular tests were selected and employed in epidemiological surveys, and HHV-8 prevalence rates were determined in different populations: children, health professionals, individuals with HIV/AIDS, female sex workers, endemic and epidemic KS cases, Amerindians, individuals with chronic renal failure, and the general population of Mozambique. Based on studies related to the pathogenesis of HHV-8 and its association with HIV/AIDS, it was observed that the antiretroviral therapy prevented the emergence of KS-AIDS cases in Brazil and suggested its use to control KS-AIDS in Africa. Finally, HHV-8 infection was confirmed in a case of peripheral effusion lymphoma (PEL). Keywords: KSHV, HHV-8, diagnosis, prevalence, viral subtypes, Kaposi’s sarcoma. |
id |
SESSP_f8b6eb679f56d3b7ede7903dd59ae7a9 |
---|---|
oai_identifier_str |
oai:ojs.periodicos.saude.sp.gov.br:article/41435 |
network_acronym_str |
SESSP |
network_name_str |
BEPA. Boletim epidemiológico paulista (Online) |
repository_id_str |
|
spelling |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ diseaseHistórico da descoberta do agente etiológico do sarcoma de Kaposi – Human Herpesvirus 8 e a atuação do Instituto Adolfo Lutz na pesquisa dessa infecção/ doençaKSHVHHV-8diagnóticoprevalênciasubtipos viraissarcoma de KaposiIn the year in which we celebrate 30 years since the discovery of the etiological agent of Kaposi's sarcoma (KS), at the time named Kaposi's sarcoma-associated herpesvirus (KSHV), later Human Herpesvirus 8 (HHV-8), the author reports on the role of the Instituto Adolfo Lutz in searching this agent using molecular biology techniques, first in biopsy material stored in paraffin and then in blood, saliva and urine, and in the characterization of subtypes and viral variants of HHV-8 that circulated in patients with KS associated with AIDS (KS-AIDS) in São Paulo, and in indigenous populations from the Brazilian Amazon. Furthermore, in-house serological techniques (indirect immunofluorescence and Western blotting) were standardized using cell lines containing HHV-8 in the latent and lytic phases of viral infection as antigens, and serum or blood collected on filter membrane to search for specific antibodies. The best cost/benefit serological and molecular tests were selected and employed in epidemiological surveys, and HHV-8 prevalence rates were determined in different populations: children, health professionals, individuals with HIV/AIDS, female sex workers, endemic and epidemic KS cases, Amerindians, individuals with chronic renal failure, and the general population of Mozambique. Based on studies related to the pathogenesis of HHV-8 and its association with HIV/AIDS, it was observed that the antiretroviral therapy prevented the emergence of KS-AIDS cases in Brazil and suggested its use to control KS-AIDS in Africa. Finally, HHV-8 infection was confirmed in a case of peripheral effusion lymphoma (PEL). Keywords: KSHV, HHV-8, diagnosis, prevalence, viral subtypes, Kaposi’s sarcoma.No ano em que se comemora 30 anos da descoberta do agente etiológico do sarcoma de Kaposi (SK), à época denominado Kaposi’s sarcoma-associated herpesvirus (KSHV), posteriormente Human Herpesvirus 8 (HHV-8), a autora descreve como se deu esta descoberta e a atuação do Instituto Adolfo Lutz na pesquisa do agente usando técnicas de biologia molecular, primeiramente em material de biópsia estocado em parafina e depois em sangue, saliva e urina, e na caracterização de subtipos e variantes virais que circulavam em pacientes com SK associado à aids (SK-aids) em São Paulo, e em populações indígenas da Amazônia brasileira. Ademais, relata a padronização de técnicas sorológicas in house (imunofluorescência indireta e Western blotting) usando como antígenos linhagens celulares contendo HHV-8 nas fases latente e lítica da infecção viral, e soro ou sangue coletado em papel de filtro para pesquisa de anticorpos específicos. Os testes sorológicos e moleculares de melhor custo/benefício foram empregados em inquéritos epidemiológicos, e determinadas taxas de prevalência de HHV-8 em diferentes populações: crianças, profissionais da saúde, indivíduos com HIV/aids, profissionais do sexo feminino, casos de SK endêmico e epidêmico, ameríndios, indivíduos com insuficiência renal crônica, e população de Moçambique. Estudos relacionados à patogênese do HHV-8 e sua associação com o HIV/aids possibilitaram observar que a terapia antirretroviral (TARV ou HAART) preveniu o surgimento de casos de SK-aids no Brasil e sugerir seu uso para controle do SK-aids na África. Por fim, foi confirmada infecção por HHV-8 em um caso de linfoma de efusão em cavidades (peripheral effusion lymphoma, PEL). Palavras-chave: KSHV, HHV-8, diagnóstico, prevalência, subtipos virais e sarcoma de Kaposi.Coordenadoria de Controle de Doenças - Secretaria de Estado da Saúde de São Paulo2024-12-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionNão avaliado pelos paresapplication/pdfhttps://periodicos.saude.sp.gov.br/BEPA182/article/view/4143510.57148/bepa.2024.v.21.41435BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435BEPA. Boletim Epidemiológico Paulista ; v. 21 (2024); e414351806-42721806-423Xreponame:BEPA. Boletim epidemiológico paulista (Online)instname:Secretaria de Estado da Saúde de São Paulo (SES-SP)instacron:SESSPporhttps://periodicos.saude.sp.gov.br/BEPA182/article/view/41435/38725Copyright (c) 2024 Adele Caterino-de-Araujoinfo:eu-repo/semantics/openAccessCaterino-de-Araujo, Adele2025-02-14T14:08:14Zoai:ojs.periodicos.saude.sp.gov.br:article/41435Revistahttps://periodicos.saude.sp.gov.br/BEPA182/indexPUBhttps://periodicos.saude.sp.gov.br/BEPA182/oaibepa@saude.sp.gov.br | periodicossp@saude.sp.gov.brhttps://doi.org/10.57148/bepa1806-42721806-423Xopendoar:2025-02-14T14:08:14BEPA. Boletim epidemiológico paulista (Online) - Secretaria de Estado da Saúde de São Paulo (SES-SP)false |
dc.title.none.fl_str_mv |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease Histórico da descoberta do agente etiológico do sarcoma de Kaposi – Human Herpesvirus 8 e a atuação do Instituto Adolfo Lutz na pesquisa dessa infecção/ doença |
title |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease |
spellingShingle |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease Caterino-de-Araujo, Adele KSHV HHV-8 diagnótico prevalência subtipos virais sarcoma de Kaposi |
title_short |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease |
title_full |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease |
title_fullStr |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease |
title_full_unstemmed |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease |
title_sort |
History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease |
author |
Caterino-de-Araujo, Adele |
author_facet |
Caterino-de-Araujo, Adele |
author_role |
author |
dc.contributor.author.fl_str_mv |
Caterino-de-Araujo, Adele |
dc.subject.por.fl_str_mv |
KSHV HHV-8 diagnótico prevalência subtipos virais sarcoma de Kaposi |
topic |
KSHV HHV-8 diagnótico prevalência subtipos virais sarcoma de Kaposi |
description |
In the year in which we celebrate 30 years since the discovery of the etiological agent of Kaposi's sarcoma (KS), at the time named Kaposi's sarcoma-associated herpesvirus (KSHV), later Human Herpesvirus 8 (HHV-8), the author reports on the role of the Instituto Adolfo Lutz in searching this agent using molecular biology techniques, first in biopsy material stored in paraffin and then in blood, saliva and urine, and in the characterization of subtypes and viral variants of HHV-8 that circulated in patients with KS associated with AIDS (KS-AIDS) in São Paulo, and in indigenous populations from the Brazilian Amazon. Furthermore, in-house serological techniques (indirect immunofluorescence and Western blotting) were standardized using cell lines containing HHV-8 in the latent and lytic phases of viral infection as antigens, and serum or blood collected on filter membrane to search for specific antibodies. The best cost/benefit serological and molecular tests were selected and employed in epidemiological surveys, and HHV-8 prevalence rates were determined in different populations: children, health professionals, individuals with HIV/AIDS, female sex workers, endemic and epidemic KS cases, Amerindians, individuals with chronic renal failure, and the general population of Mozambique. Based on studies related to the pathogenesis of HHV-8 and its association with HIV/AIDS, it was observed that the antiretroviral therapy prevented the emergence of KS-AIDS cases in Brazil and suggested its use to control KS-AIDS in Africa. Finally, HHV-8 infection was confirmed in a case of peripheral effusion lymphoma (PEL). Keywords: KSHV, HHV-8, diagnosis, prevalence, viral subtypes, Kaposi’s sarcoma. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-12-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Não avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435 10.57148/bepa.2024.v.21.41435 |
url |
https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435 |
identifier_str_mv |
10.57148/bepa.2024.v.21.41435 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435/38725 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2024 Adele Caterino-de-Araujo info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2024 Adele Caterino-de-Araujo |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Coordenadoria de Controle de Doenças - Secretaria de Estado da Saúde de São Paulo |
publisher.none.fl_str_mv |
Coordenadoria de Controle de Doenças - Secretaria de Estado da Saúde de São Paulo |
dc.source.none.fl_str_mv |
BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435 BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435 BEPA. Boletim Epidemiológico Paulista ; v. 21 (2024); e41435 1806-4272 1806-423X reponame:BEPA. Boletim epidemiológico paulista (Online) instname:Secretaria de Estado da Saúde de São Paulo (SES-SP) instacron:SESSP |
instname_str |
Secretaria de Estado da Saúde de São Paulo (SES-SP) |
instacron_str |
SESSP |
institution |
SESSP |
reponame_str |
BEPA. Boletim epidemiológico paulista (Online) |
collection |
BEPA. Boletim epidemiológico paulista (Online) |
repository.name.fl_str_mv |
BEPA. Boletim epidemiológico paulista (Online) - Secretaria de Estado da Saúde de São Paulo (SES-SP) |
repository.mail.fl_str_mv |
bepa@saude.sp.gov.br | periodicossp@saude.sp.gov.br |
_version_ |
1838465361196875776 |